ESMO – Eur. Oncology shared an article by D.J. McGrail on X:
” To mark 35 years of Annals of Oncology, we spotlight a 2023 top-cited paper: “High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types.”
Authors: D.J. McGrail, et al.
